لابراتوارهای دارویی رازک
درازک | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 5,650 2.92
Close Price: 5,680
Income Statement
AGM
Interim
2026/07/19 Fiscal Year 2026/03/2012 Month | 2025/06/17 Fiscal Year 2025/03/2012 Month | 2024/07/31 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 20.619 Trillion | 10.999 Trillion | 10.646 Trillion | |
Total Revenues | 20.619 Trillion | 10.999 Trillion | 10.646 Trillion | |
Cost of Goods Sold | 14.092 Trillion | 9.514 Trillion | 8.54 Trillion | |
Gross Profit | 6.527 Trillion | 1.486 Trillion | 2.105 Trillion | |
General & Administrative Expenses | 1.14 Trillion | 705.95 Billion | 660.014 Billion | |
Net Operating Income & Expenses | -94.537 Billion | -367.256 Billion | -285.202 Billion | |
Operating Profit (Loss) | 5.292 Trillion | 412.498 Billion | 1.16 Trillion | |
Profit Before Tax | 4.834 Trillion | 247.772 Billion | 959.141 Billion | |
Tax | 306.646 Billion | - | 741.163 Billion | |
Net Profit (Loss) After Tax | 4.528 Trillion | 10.982 Billion | 217.978 Billion | |
Retained Earnings at Beginning of Period | 290.709 Billion | 580.027 Billion | 5.673 Trillion | |
Prior-Year Tax | - | 236.79 Billion | - | |
Approved Dividends — Prior Year AGM | -2.1 Billion | -300.3 Billion | -5.311 Trillion | |
Allocable Profit | 4.816 Trillion | 290.709 Billion | 580.027 Billion | |
Legal Reserve | 226.387 Billion | - | - | |
Approved Dividends — Current Year | 1.743 Trillion | 2.1 Billion | 300.3 Billion | |
Retained Earnings at End of Period | 2.847 Trillion | 288.609 Billion | 279.727 Billion |